Latest NewsOct 30, 2025HiFiBiO Therapeutics Announces the Appointment of Leading I&I Experts to its Scientific Advisory BoardAll Filter By: Year20252024202320222021202020192018201720162015Sep 14, 2024HiFiBiO Therapeutics to Present Phase 1 Clinical Trial Data for Two Novel Immuno-Oncology Antibodies at the 2024 Annual Congress of the European Society for Medical OncologyJun 13, 2024EY Announces Liang Schweizer of HiFiBiO Therapeutics as an Entrepreneur Of The Year® 2024 New England Award WinnerMay 24, 2024HiFiBiO Therapeutics to Present Phase 1 Clinical Trial Data for Two Novel Immuno-Oncology Agonists at the 2024 Annual Meeting of the American Society of Clinical OncologyApr 17, 2024EY Announces Liang Schweizer of HiFiBiO Therapeutics as an Entrepreneur Of The Year® 2024 New England Award FinalistApr 16, 2024HiFiBiO Therapeutics Receives Grant to Research Long COVID and ME/CFS in Collaboration with UMass Chan Medical School< 1 2 3 4 … 18 >
